Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-14 08:00 |
Fagron jaarverslag 2023 FINAL.pdf
|
Dutch | 8.4 MB | ||
| 2024-02-15 07:33 |
Fagron delivers strong performance with 12% topline growth and 14% increase in …
|
English | 412.0 KB | ||
| 2024-02-15 07:00 |
Fagron delivers strong performance with 12% topline growth and 14% increase in …
|
English | 412.0 KB | ||
| 2024-02-15 07:00 |
Fagron levert sterke prestatie met 12% omzetgroei en 14% REBITDA groei voor FY …
|
Dutch | 358.0 KB | ||
| 2024-01-08 08:18 |
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
|
Dutch | 142.4 KB | ||
| 2024-01-08 08:18 |
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold
|
English | 177.1 KB | ||
| 2024-01-08 08:00 |
AOC Pharma Sarl - Transparency notification (upward crossing) 27 December 2023.…
|
English | 1.1 MB | ||
| 2024-01-08 08:00 |
Disclosure notification from AOC Pharma S.à r.l. – passing 10% threshold.pdf
|
English | 177.1 KB | ||
| 2024-01-08 08:00 |
Openbaarmaking kennisgeving van AOC Pharma S.à r.l. – passering 10% drempel.pdf
|
Dutch | 142.4 KB | ||
| 2023-12-12 07:32 |
Disclosure of notification received from BNP Paribas Asset Management SA
|
Dutch | 100.3 KB | ||
| 2023-12-12 07:32 |
Disclosure of notification received from BNP Paribas Asset Management SA
|
English | 102.1 KB | ||
| 2023-12-11 18:00 |
BNP Paribas Asset Management SA - Transparency notification (downward crossing)…
|
Dutch | 279.2 KB | ||
| 2023-12-11 18:00 |
Disclosure shareholder notification BNP Paribas Asset Management SA.pdf
|
English | 102.1 KB | ||
| 2023-12-11 18:00 |
Openbaarmaking van kennisgeving ontvangen van BNP Paribas Asset Management SA.p…
|
Dutch | 100.3 KB | ||
| 2023-11-10 07:46 |
Disclosure of notification received from BNP Paribas Asset Management SA
|
English | 102.6 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
